Please login or register first to view this content.
Respiratory Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Additional Data Support Efficacy of Molnupiravir for Mild to Moderate COVID-19
Nasal Nerve Disruption Therapy Cleared for In-Office Treatment of Chronic Rhinitis
Drug Shortage and Manufacturing Delays for Zemaira
Yutrepia Gets Tentative Approval for Pulmonary Arterial Hypertension
The Effects of Rhinovirus in Children With Severe Wheeze
Allergen Immunotherapy for Allergic Rhinitis Has Favorable Real-World Outcomes
Can Biologics Cut Steroid Exposure in Aspirin-Exacerbated Respiratory Disease?
Shorter, Low-Dose Amoxicillin Feasible for Pediatric Community-Acquired Pneumonia
Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89%
Results Mixed for Use of Zinc for Acute Viral RTIs in Adults
USPSTF Still Advises Against COPD Screening for Asymptomatic Adults
Risankizumab Not Beneficial for Severe Asthma in Adults
Higher Dose of Steroid Does Not Improve Outcomes in Severe COVID-19
Itepekimab Bests Placebo for Moderate-to-Severe Asthma
Alvelestat Designated Orphan Drug for Alpha-1 Antitrypsin Deficiency
Dupixent Asthma Indication Expanded to Include Younger Patients
Real-World Efficacy of Biologics For Patients With Severe, Uncontrolled Asthma
Biologic Therapies Available for Pediatric Patients With Asthma